J
Josemir W. Sander
Researcher at UCL Institute of Neurology
Publications - 705
Citations - 44517
Josemir W. Sander is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Epilepsy & Population. The author has an hindex of 106, co-authored 680 publications receiving 39038 citations. Previous affiliations of Josemir W. Sander include University of Cincinnati & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Cause of death and predictors of mortality in a community-based cohort of people with epilepsyAuthor Response
TL;DR: A cohort study of patients with any kind of first afebrile epileptic seizure, which by definition has a different case mix than a cohort of epilepsy patients, is cited.
Journal ArticleDOI
Partial epilepsy syndrome in a Gypsy family linked to 5q31.3-q32
Dora Angelicheva,Ivailo Tournev,Ivailo Tournev,Velina Guergueltcheva,V. Mihaylova,Dimitar N. Azmanov,Bharti Morar,Melania Radionova,Shelagh J.M. Smith,Dora Zlatareva,John Stevens,Radka Kaneva,Veneta Bojinova,Kim W. Carter,Matthew A. Brown,Assen Jablensky,Luba Kalaydjieva,Josemir W. Sander +17 more
TL;DR: In this article, the authors explored the genetic basis of epilepsies in one such population, the Gypsy family, and identified a novel locus on 5q31.3-q32 with an logarithm of the odds (LOD) score of 3 corresponding to the expected maximum.
Journal ArticleDOI
The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: A study on levetiracetam
TL;DR: LEV treatment is not associated with cognitive adverse events and depression in patients with hippocampal sclerosis.
Journal ArticleDOI
Cancer risk in people with epilepsy using valproate-sodium.
Gagandeep Singh,Gail S. Bell,Gail S. Bell,P. Hernáiz Driever,Josemir W. Sander,Josemir W. Sander +5 more
TL;DR: People with epilepsy using valproate‐sodium as a treatment for epilepsy may be at increased cancer risk, according to a study published in Acta Neurol Scand.